Ligand-mediated chronic activation of EGFR is necessary for gliomagenesis in mice [41], and this association might be consistent with our finding of time-stable, elevated serum EGFR and ErbB2 levels in glioblastomas. The gene discussed is ERBB2; the disease is glioblastoma.